Literature DB >> 15322448

Multiple sclerosis with severe pain and allodynia alleviated by oral ketamine.

Tetsuya Sakai1, Shiro Tomiyasu, Takeshi Ono, Hiroyuki Yamada, Koji Sumikawa.   

Abstract

The objective of this study is to determine the effect of oral ketamine on pain and allodynia associated with multiple sclerosis. A 60-year-old woman with multiple sclerosis was referred to our clinic because of severe pain and allodynia. Oral ketamine was started at a dose of 20 mg once a day and increased to twice a day. Oral ketamine was effective in the treatment of the pain and allodynia associated with multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322448     DOI: 10.1097/00002508-200409000-00016

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

1.  Low-dose ketamine provides poor analgesia for pain in redback spider envenoming.

Authors:  Nicole M Ryan; Rosemary James; Michael A Downes; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2019-08-06       Impact factor: 4.335

Review 2.  Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome.

Authors:  Eliezer Soto; Douglas R Stewart; Andrew J Mannes; Sarah L Ruppert; Karen Baker; Daniel Zlott; Daniel Handel; Ann M Berger
Journal:  Am J Hosp Palliat Care       Date:  2011-07-29       Impact factor: 2.500

3.  Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report.

Authors:  Michael M Messer; Irina V Haller
Journal:  Innov Clin Neurosci       Date:  2017-02-01

Review 4.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

6.  Neuropathic pain in animal models of nervous system autoimmune diseases.

Authors:  David H Tian; Chamini J Perera; Gila Moalem-Taylor
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.